Fri, April 5, 2013
Thu, April 4, 2013
Wed, April 3, 2013
Tue, April 2, 2013
Mon, April 1, 2013
Fri, March 29, 2013
Thu, March 28, 2013
Wed, March 27, 2013
Tue, March 26, 2013
Mon, March 25, 2013
[ Mon, Mar 25th 2013 ] - Market Wire
Health Canada Decision Appealed
Sun, March 24, 2013
Fri, March 22, 2013
Thu, March 21, 2013
Wed, March 20, 2013
[ Wed, Mar 20th 2013 ] - Market Wire
00am ET
Tue, March 19, 2013
Mon, March 18, 2013
Sun, March 17, 2013
Fri, March 15, 2013
Thu, March 14, 2013
Wed, March 13, 2013
Tue, March 12, 2013
Mon, March 11, 2013
Sun, March 10, 2013
Sat, March 9, 2013
Fri, March 8, 2013

Harwood Feffer LLP Announces Investigation of Obagi Medical Products, Inc.


//health-fitness.news-articles.net/content/2013/ .. investigation-of-obagi-medical-products-inc.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Harwood Feffer LLP Announces Investigation of Obagi Medical Products, Inc. -- NEW YORK, March 21, 2013 /PRNewswire/ --

NEW YORK, March 21, 2013 /PRNewswire/ -- Harwood Feffer LLP ([ www.hfesq.com ]) is investigating potential claims against the board of directors of Obagi Medical Products, Inc. ("OMPI" or the "Company") (NASDAQ: [ OMPI ]) concerning the proposed acquisition of the Company to Valeant Pharmaceuticals International, Inc. ("Valeant") in a transaction valued at approximately $360 million.    

(Logo: [ http://photos.prnewswire.com/prnh/20120215/MM54604LOGO ] )

On March 20, 2013, OMPI announced that it had entered into a definitive agreement pursuant to which the Company will be acquired by Valeant.  Under the terms of the agreement, OMPI stockholders will receive $19.75 in cash for each share held. 

Our investigation concerns whether the OMPI board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders. 

If you own OMPI shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin Sachs-Michaels, Esq.   
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: [ bsachsmichaels@hfesq.com ]
Website: [ http://www.hfesq.com ]

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ([ http://www.hfesq.com ]) for more information about the firm.

Attorney Advertising © 2013 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ([ www.hfesq.com ]). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Harwood Feffer LLP



RELATED LINKS
[ http://www.hfesq.com ]

Publication Contributing Sources